Nitrous Oxide Market Size, Trends, Shares, Insights Forecast 2025

Market Research Future Published a Research Study on Fullerene Market Research Report, Size, Share and Industry Analysis- Forecast to 2025According to the MRFR analysis, the Global Fullerene Market is estimated to exhibit a CAGR of 15%Fullerene is an allotropic form of carbon and is made of hollow cage structure.

Fullerene finds a wide range of applications in cosmetics, renewable energy, automotive, electronics, and semiconductor industries.

However, according to Globally Harmonized System of Classification and Labelling of Chemicals (GHZ) fullerene is classified as H228 (flammable solid) and H315-H319 (causes skin irritation and serious eye irritation).Get a FREE Sample Report Now@ https://www.marketresearchfuture.com/sample_request/8343Key PlayersVitamin C60 BioResearch Corporation (China)—LipoFullereneNano-C (US)Frontier Carbon Corporation (Japan)—nanom purple STSolenne BV (The Netherlands)MTR Ltd (US)BuckyUSA (US)American Elements (US)Nanostructured & Amorphous Materials, Inc (US)NeoTechProduct (RUSSIA)Xiamen Funano New Material Technology Company LTD (China)Merck KGaA (Germany)SegmentationBy TypeC60: C60 fullerene is most widely used in cosmetics, pharmaceuticals, and semiconductor applications.

The segment accounted for more than 60% share in 2018 and is projected to register highest growth owing to wide range of applicationsC70: It is mainly used as organic photovoltaics (OPV), catalysts and antioxidants.

Furthermore, the increasing use of fullerene for cancer treatments and usage as a drug delivery system is expected to boost the segment’s growth during the forecast period.Cosmetics: The segment is expected to be the fastest-growing in the market.

Fullerene owing to its antioxidant characteristics is used as an anti-aging and anti-damage agent in the cosmetic sector.

Market Research Future Published a Half-Cooked Research Report on Global PTFE Membrane Market Research Report- Forecast to 2023Market Segmentation:Global PTFE Membrane Market Size has been segmented on the basis of type and application.Type-Wise, the segments in the market are hydrophobic PTFE membrane, hydrophilic PTFE membrane.Application-Based Segments are industrial filtration, textiles, medical & pharmaceuticals, water treatment industry, architecture, and others.Regional Insight:The Key Markets for PTFE Membrane are Latin America, Asia Pacific, Europe, Middle East & Africa and North America.Asia Pacific is identified as the most significant PTFE Membrane Market, with North America and Europe coming in second and third, respectively.

Other than that, increasing population, mostly in India and China accelerates the need for safe and clean water, which drives the demand for PTFE Membrane within the water treatment facilities.

Highly developed manufacturing units, pharmaceutical, and oil & gas industries contribute massively to the market growth.

The primary nations responsible for the lucrative market in the region are Italy, the United Kingdom (U.K) and Germany among others.

Spike in demand for PTFE Membrane within the medical & pharmaceutical and water & wastewater treatment applications could quite possibly lead to further market expansion in the following years.Market Overview:Market Research Future (MRFR) expects the Global Polytetrafluoroethylene (PTFE) Membrane Market to reach a CAGR of 9% during the forecast period (2018-2023).Prominent Companies:Some of the leading companies shaping the worldwide PTFE Membrane Market include Donaldson Company, Inc. (U.S.), Hyundai Micro Co., (South Korea), General Electric (U.S.), Sartorius AG (Germany), Markel Corporation (U.S.), Layne Christensen Company (U.S.), Pall Corporation (U.S.), Merck KGaA.

(U.S.), W. L. Gore & Associates, Inc. (U.S.), Zeus Incorporation (U.S.), among others.Browse Key Industry Insights spread across 137 pages with 44 market data tables & 11 figures & charts from the report, “PTFE Membrane Market Information: Type (Hydrophobic PTFE Membrane), Application (Industrial Filtration, Textiles, Medical & Pharmaceutical, Architecture, Others) and Region – Growth Potential, Price Trends, Competitive Market Share & Forecast 2023” in detail along with the table of contents: https://www.marketresearchfuture.com/reports/ptfe-membrane-market-5696Market Drivers and Key Restraints:PTFE is a type of thermoplastic polymer which is known for having exceptional properties including enhanced flexibility, self-lubricating properties as well as high tensile strength, among others.

The global Antiseptic Bathing Products Market for is projected to reach USD 17.13 billion by the end 2025, according to a new report released by Million Insights.

Rising need for antiseptic bathing products to reduce the risk of pathogenic infections, nosocomial infections, skin allergies, and infections at surgical sites is expected to drive the demand for this product over the forecast period.

Key Players:Ecolab Inc.; 3M; Becton Dickinson & Co.; Colorox Company; Air Liquide; Medline Industries; Stryker Corporation; Molnlycke Healthcare AB; Reckitt Benckiser Nigeria Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/global-antiseptic-bathing-products-market/request-sample Market Synopsis of Antiseptic Bathing Products Market:  Rising incidences of infections at surgical sites are expected to boost the application of this product.

According to a report released by National Nosocomial Infections Surveillance, in U.S., every year out of 27 million cases, 5% cases are of surgical site infections.

The segment of CHG Solutions lead the global antiseptic bathing products market with a revenue of USD 3.57 Million.

Usage in surgical wards followed by Intensive Care Units (ICUs) is expected to boost the demand for the product from 2019 to 2025.

The most recently published Alum And Calcium Salts Market report provides a critical assessment of key growth dynamics, emerging pathways, investment trends in key regional markets, and the competitive landscape in various regions and key players’ strategies.

The study also offers insights into the proportion and size of various segments of the Alum And Calcium Salts market.

The report presents the market analysis based on several factors.

To better understand customers, he uses effective graphic presentation techniques such as charts, graphs, tables, and images.Get Free Sample PDF @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-alum-and-calcium-salts-marketThe report covers a wide range of areas for a better global market experience as well as industry trends and forecasts.

In this report, variables influencing the market such as drivers, controls, and store openings have been carefully described.

These influencing factors are the socio-political situation, environmental conditions, demographics, legal organizations, and the competitive environment in the region.Market ScopeThe research report is committed to giving its readers an unbiased point of view of the global Alum And Calcium Salts market.

The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 913.3 million in 2017, at a CAGR of 13.2%.

Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination.

The booming biopharma industry in emerging countries is also expected to offer a wide range of growth opportunities to players in the market.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832 Market Dynamics Driver: Rising Demand for Low-Cost Biologic Drugs At present, there is a rising demand for low-cost biologic drugs.

According to the US Census Bureau, in 2015, an estimated 8.5% (or 617.1 million individuals) of the global population was aged 65 years and older; by 2030, this figure is estimated to reach 22%.

These markets lack proper standards and government regulations and thus offer significant growth potential for providers that are unable to meet the stringent regulatory standards in the US and European Union (EU).

The variety of species of mycoplasmas can cause various diseases which are related to genitourinary, respiratory, cardiovascular, musculoskeletal, and gastrointestinal and other diseases such as diseases related to hematopoietic system, cutaneous system related diseases such as Erythema Nodosum, Cutaneous Leukocytoclastic Vasculitis, Stevens -Johnson syndrome.

The major disease causing species includes Mycoplasma pneumoniae, M genitalium, U parvum, U urealyticum, M. homini and C. pneumoniae.Asia Pacific mycoplasma testing in clinical market is projected to register a healthy CAGR of 12.6% in the forecast period of 2019 to 2026.

Get Sample Report at : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-mycoplasma-testing-in-clinical-market Competitive Analysis: Asia-Pacific  Mycoplasma Testing in Clinical   MarketSome of the major players operating in this market are Sartorius AG, MERCK KGAA, ELITechGROUP, AB ANALITICA srl, GOLD STANDARD DIAGNOSTICS, OSANG Healthcare, BioFire Diagnostics, PromoCell GmbH, Lonza, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Liofilchem Srl, ZEAKON Diagnostics, OPERON, Bio-Rad Laboratories, Inc., Sacace Biotechnologies Srl andSeegene Inc., among othersKey Pointers Covered in the Asia-Pacific  Mycoplasma Testing in Clinical Market Trends and Forecast to 2026Asia-Pacific  Mycoplasma Testing in Clinical Market New Sales VolumesAsia-Pacific  Mycoplasma Testing in Clinical Market Replacement Sales VolumesAsia-Pacific  Mycoplasma Testing in Clinical Market Installed BaseAsia-Pacific  Mycoplasma Testing in Clinical Market By BrandsAsia-Pacific  Mycoplasma Testing in Clinical Market SizeAsia-Pacific  Mycoplasma Testing in Clinical Market Procedure VolumesAsia-Pacific  Mycoplasma Testing in Clinical Market Product Price AnalysisAsia-Pacific  Mycoplasma Testing in Clinical Market Healthcare OutcomesAsia-Pacific  Mycoplasma Testing in Clinical Market Cost of Care AnalysisAsia-Pacific  Mycoplasma Testing in Clinical Market Regulatory Framework and ChangesAsia-Pacific  Mycoplasma Testing in Clinical Market Prices and Reimbursement AnalysisAsia-Pacific  Mycoplasma Testing in Clinical Market Shares in Different RegionsRecent Developments for Asia-Pacific  Mycoplasma Testing in Clinical Market CompetitorsAsia-Pacific  Mycoplasma Testing in Clinical Market Upcoming ApplicationsAsia-Pacific  Mycoplasma Testing in Clinical Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-mycoplasma-testing-in-clinical-marketScope of the  Mycoplasma Testing in Clinical   MarketAsia-Pacific Mycoplasma Testing in Clinical Market By Products (Kits and Reagents, Instruments, Services), Technique (Microbial Culture Techniques/Direct Assay, Polymerase Chain Reaction, ELISA, DNA Staining/Indirect Assay, Enzymatic Methods, Others), Disease Area (Respiratory, Urogenital, Gastrointestinal, Cardiovascular, Musculoskeletal, Others), End User (Diagnostic Laboratories, Hospitals, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026The mycoplasmas are self-replicating bacteria.

The major disease causing species includes Mycoplasma pneumoniae, M genitalium, U parvum, U urealyticum, M. homini and C. pneumoniae.These mycoplasma causes number of diseases which have been identified by various kits & reagents and instruments.

The kits & reagents used in techniques such as mycoplasma detection assay helps in identifying particular mycoplasma, instruments such as PCR, real-time PCR, reader and others.Market Segmentation: Asia-Pacific  Mycoplasma Testing in Clinical  MarketGlobal Mycoplasma Testing in Clinical Market is segmented into kits and reagents, instruments and servicesIn March, 2018 Agilent Technologies, Inc. had announced acquisition of Advanced Analytical Technologies, Inc.

Due to this company enhance their product portfolio and also enhances image of the company in the market.On the basis of technique, the market is segmented into polymerase chain reaction, ELISA, DNA staining/ indirect assay, enzymatic methods, microbial culture techniques /direct assay and othersIn March 2019, F. Hoffmann-La Roche Ltd announced launch of its product cobas TV/MG on the cobas 6800/8800 Systems.

The key research methodology employed throughout this report by DBMR research team is data triangulation which entails data mining, analysis of the impact of data variables on the Market, and primary validation.

Edit the report in the executive summary 4.

Go over the types of data used in drawing conclusions 8.

State conclusions and call the reader to action.Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market .The Global Enzyme Immunoassay (EIA) Reagents and Devices Market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.According to market research study, Enzyme immunoassay (EIA) reagents and devices are used to detect the presence or concentration of an antigen with its application to epidemiological diseases detection.

The devices are fragmented on the basis of technology and are used for a wide range of applications such as oncology, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.The most significant key factors driving the growth of the Global Enzyme Immunoassay (EIA) Reagents and Devices Market are rising prevalence of chronic and infectious diseases coupled with rising geriatric population, rising research and developmental proficiencies by the pharmaceutical companies in order to come up with innovative drugs and healthcare technologies.Global Enzyme Immunoassay (EIA) Reagents and Devices Market Segmentation:Based on the Technology, the enzyme immunoassay (EIA) reagents and devices market is segmented into enzyme immunoassays, fluorescent immunoassays, chemiluminescence, immunoassays, radioimmunoassay and others.Based on the Product type, the enzyme immunoassay (EIA) reagents and devices market is segmented into analysers and reagents.Based on the Application, the enzyme immunoassay (EIA) reagents and devices market is segmented into oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.Based on the End-Users, the enzyme immunoassay (EIA) reagents and devices market is segmented into hospitals, laboratories, academics, pharmaceutical industries and others.Regionally, North America dominates the enzyme immunoassay (EIA) reagents and devices market is expected to continue its dominant trend during the forecast period.

This is because of the increased focus to develop novel drugs and biomarkers for various kinds of diseases.

Expected Revenue Growth:The filter integrity test market is projected to reach USD 79 million by 2024 from USD 59 million in 2018, at a CAGR of 5.0% during the forecast period.Accessories to Fuel the Growth of Filter Integrity Test Market :Based on end user, the filter integrity test market is segmented into pharmaceutical and biopharmaceutical companies, CMOs, and other end users.

This segment is also expected to witness the highest growth during the forecast period owing to the growing biopharmaceutical industry, significant growth in the biologics market, and stringent government guidelines for purity requirements in pharmaceutical and biotechnology manufacturing.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46873904By type, the diffusion test segment to register the highest growth rate in the filter integrity test market during the forecast period.Based on type, the market is segmented into diffusion test, water flow integrity test, and bubble point test.

This segment is also expected to witness the highest growth during the forecast period.

The advantages offered by the diffusion testing method such as high sensitivity, high margin of safety, and testing of the complete filter system (cartridge and housing) are supporting the growth of this segment.By mechanism, the automated filter integrity test segment to register the highest growth during the forecast period.Based on mechanism, the filter integrity test market is segmented into automated and manual filter integrity tests.

In automated integrity testing, the data is not manually entered into the integrity test instrument, which reduces the risk of human error.

Moreover, the filter can be tested in-line without the user having to initiate the test manually, and test results are automatically transferred to a data storage module.

This report aims to provide detailed insights into the global healthcare analytical testing services market.

It provides valuable information on the type, procedure, application, and region in the market.

Revenue Growth Analysis: The global Healthcare Analytical Testing Services Market size is projected to reach USD 8.4 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 11.4% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833 Key Factors Driving Market Growth: Factors such as the increased outsourcing of analytical testing services by pharmaceutical companies, rising focus on specialized testing services for biologics and biosimilars, and the growing number of clinical trials are expected to drive the growth of the healthcare analytical testing services market.

By type, the bioanalytical testing services segment is expected to dominate the healthcare analytical testing services market in 2020 Based on type, the analytical testing services has been segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, batch-release testing services, stability testing services, microbial testing services, and environmental monitoring services.

The medical device companies market is estimated to show the highest CAGR in the forecast period, as analytical testing companies are seeing more requests from OEMs for material characterization testing for medical devices and materials.

The Growth in the Single cell Analysis Market is mainly driven by the technological advancements in single-cell analysis products, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.

Growth of the market is primarily driven by the technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and pharmaceutical industries, wide applications of single-cell analysis in cancer research.

According to Latest Market research report Published by MarketsandMarkets the “Single cell Analysis Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach US $ 3.59 Billion, at a CAGR of 16.5% Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254 The key strategies followed by most companies in the market are new product launches; partnerships, agreements, collaborations; acquisitions; and approvals.

It is a well-known company and has an exhaustive product portfolio.

The company is innovation-centric and invests heavily in R for maintaining its market share.

Moreover, the company focuses on inorganic growth strategies such as acquisitions for enhancing its share.Thermo Fisher Scientific acquired Life Technologies, a leading player in the life sciences business to expand its product offerings.Major Drivers Impacting the Single-cell Analysis Market;Technological Advancements in Single-Cell Analysis ProductsIncreasing Government Funding for Cell-Based ResearchGrowing Biotechnology and Biopharmaceutical IndustriesWide Applications of Single-Cell Analysis in Cancer ResearchGrowing Focus on Personalized MedicineIncreasing Incidence and Prevalence of Chronic and Infectious Diseases Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254 Global Single-cell Analysis Market Segmentation: On the basis of product, the market is segmented into consumables and instruments.

North America oligonucleotides synthesis market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures.

Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.Download Exclusive Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-oligonucleotides-synthesis-marketCompetitive Analysis: North America Oligonucleotides Synthesis Market Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Product LaunchesIn July 2019, Twist Bioscience Corporation launched long oligonucleotides product line which is designed up to 300 nucleotides and is longest commercial oligo which helps in continuous chemical synthesis.

The launch of new product helps in enhancing the product offering of company and enhancing the biological research activity with the help of longest synthetic oligos.In May 2019, QIAGEN announced launch of PIK3CA RGQ PCR kit to improve the health of patient with breast cancer.

This uses plasma specimens during liquid biopsy.

With this there will be improved diagnostics for genetic abnormalities and hence increased product portfolio of a company.To Insightful Report Details Visit https://www.databridgemarketresearch.com/reports/north-america-oligonucleotides-synthesis-marketSegmentation: North America Oligonucleotides Synthesis Market North America oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.·       On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.·       On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.·       On the basis of technique, the market is segmented into polymerase chain reaction, ELISA, DNA staining/ indirect assay, enzymatic methods, microbial culture techniques /direct assay and others·       On the basis of consumables, the market is segmented into instruments, kits & reagents and others.·       On the basis of disease area, the market is segmented into urogenital, respiratory, cardiovascular, musculoskeletal, gastrointestinal and others·       On the basis of service type, the market is segmented into custom oligos, predesigned oligos and oligo synthesis.·       On the basis of end user, the market is segmented into hospitals, diagnostic laboratories and others·       On the basis of application, the market is segmented into research applications, therapeutic applications, diagnostic applications and others.·       On the basis of end user, the market is segmented into bio-pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, hospitals and others.Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/north-america-oligonucleotides-synthesis-marketResearch Methodology: North America Oligonucleotides Synthesis Market Primary Respondents:Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-oligonucleotides-synthesis-marketBrowse Trending Related Reports @·       Cardiac Rhythm Management Market·       Exosome Research Products Market·       Image-Guided Radiation Therapy Market·       Metagenomics Market·       Sutures MarketAbout Data Bridge Market Research:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.

We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the marketContact:Data Bridge Market ResearchTel: +1-888-387-2818Email: [email protected]

Market HighlightsCell counting market is expected to witness positive growth in future as it has wide range of applications in research institutes, hospitals, biotechnology and pharmaceuticals companies and it an important tool in research, drug discovery and biopharmaceutical applications.

Increasing prevalence of cancer and rising geriatric population are major driver for the market growth.

Furthermore, factors responsible for the growth of the cell counting market in Asia Pacific are rising awareness regarding prevalence of disease such as cancer and other lifestyle diseases and improvement in healthcare facilities.

High cost of cell counting instruments may create an obstacle for the market growth.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/628Asia Pacific cell counting market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023.Asia-Pacific Cell Counting Market Players:Key players in cell counting market are Bio-Rad Laboratories Inc. (U.S), General Electric Company (U.S), Agilent Technologies (U.S), PerkinElmer Inc. (U.S), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S), Danaher (U.S), Merck KGaA (U.S).Segmentation:The Asia Pacific cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments.

On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications.

Regional Analysis:Asia Pacific cell counting market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia Pacific.